Correlation Between X4 Pharmaceuticals and Arvinas

Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between X4 Pharmaceuticals and Arvinas, you can compare the effects of market volatilities on X4 Pharmaceuticals and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Arvinas.

Diversification Opportunities for X4 Pharmaceuticals and Arvinas

0.07

Correlation Coefficient

X4 Pharmaceuticals  Arvinas

Significant diversification

The 3 months correlation between XFOR and Arvinas is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Arvinas go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Arvinas

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Arvinas. In addition to that, X4 Pharmaceuticals is 2.91 times more volatile than Arvinas. It trades about -0.02 of its total potential returns per unit of risk. Arvinas is currently generating about 0.04 per unit of volatility. If you would invest  2,550  in Arvinas on September 2, 2024 and sell it today you would earn a total of  122.00  from holding Arvinas or generate 4.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

X4 Pharmaceuticals  vs.  Arvinas

X4 Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Arvinas

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Arvinas are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Arvinas may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with X4 Pharmaceuticals and Arvinas

The main advantage of trading using opposite X4 Pharmaceuticals and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.

The idea behind X4 Pharmaceuticals and Arvinas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.